- Location
1
result for "
Degarelix Acetate
"-
Gonax Is Designed to Inhibit The Binding of GnRH
Nov 28, 2012Astellas Pharma has introduced Gonax (Degarelix Acetate), a gonadotrophin-releasing hormone (GnRH)-receptor blocker, for subcutaneous injection to treat prostate cancer in Japan. Gonax is designed to inhibit the binding of GnRH, a hormone ...
Related Products
-
CAS 214766-78-6 Degarelix Pharmaceutical Raw Material
-
Hota Supply Peptides Degarelix Powder Degarelix Acetate CAS 214766-78-6
-
Pharmaceutical Intermediates Powder Peptides Acetate Anti-Cancer Drug Degarelix CAS 214766-78-6
-
Raw Material Powder Peptides Acetate Anti-Cancer Drug Degarelix CAS 214766-78-6
-
High Quality 99% CAS No 214766-78-6 Degarelix Acetate Powder
-
Degarelix CAS No. 214766-78-6
